Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84−0.03 (-3.91%)
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Allarity Therapeutics r&d expenses
Research and development expenses are spending on new products and technology.
Allarity Therapeutics's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.52M, down 16.3% year over year. For fiscal 2025 it was $6.60M, up 8.3% from the year before. The highest annual figure on record is $14.20M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.60M | +8.3% |
| FY2024 | Dec 31, 2024 | $6.10M | -14.2% |
| FY2023 | Dec 31, 2023 | $7.10M | +2.5% |
| FY2022 | Dec 31, 2022 | $6.93M | -51.2% |
| FY2021 | Dec 31, 2021 | $14.20M | +236.6% |
| FY2020 | Dec 31, 2020 | $4.22M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.35M | -42.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.30M | -7.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.67M | -9.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.20M | +17.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.32M | +119.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.40M | -35.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.85M | -29.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.02M | -47.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.06M | +12.4% |
| Q1 FY2024 | Mar 31, 2024 | $2.17M | -27.8% |
| Q4 FY2023 | Dec 31, 2023 | $2.62M | +54.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.95M | +51.1% |
| Q4 FY2022 | Dec 31, 2022 | $941.00K | -90.1% |
| Q3 FY2022 | Sep 30, 2022 | $3.00M | +121.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.70M | -25.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.29M | +3.0% |
| Q4 FY2021 | Dec 31, 2021 | $9.52M | +471.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.36M | +72.6% |
| Q2 FY2021 | Jun 30, 2021 | $2.28M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.25M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.67M | – |
| Q3 FY2020 | Sep 30, 2020 | $785.00K | – |
See a number that looks wrong?